Sjögren’s syndrome affects roughly 61 out of every 100,000 people worldwide, making it rare enough to qualify as an orphan disease in both the United States and Europe. The NIH’s Genetic and Rare Diseases Information Center officially lists it as a rare disease. Yet because its hallmark symptoms, dry eyes and dry mouth, overlap with so many other conditions, the true number of people living with Sjögren’s is almost certainly higher than the statistics suggest.
Prevalence by the Numbers
The global prevalence of Sjögren’s syndrome sits at about 0.06%, or 3 to 10 cases per 10,000 people depending on the population studied and the diagnostic criteria used. When researchers look specifically at primary Sjögren’s, the form that develops on its own rather than alongside another autoimmune condition, the numbers drop further. A French national claims-based study found the prevalence of primary Sjögren’s ranged from 23 to 32 per 100,000 people, low enough to meet the threshold for orphan disease status in Europe.
For context, rheumatoid arthritis affects roughly 1 in 100 people, and lupus affects somewhere around 1 in 1,000. Sjögren’s falls well below both, though it’s more common than many people realize given how rarely it comes up in public conversation. It ranks among the more common autoimmune diseases overall, but among the rarest that most people have never heard of.
Who Gets Sjögren’s Syndrome
Women account for about 93% of all diagnoses. The ratio of men to women is approximately 1 to 15, one of the most lopsided gender gaps in autoimmune disease. The average age at diagnosis is 51, though it can appear at any point between the fourth and sixth decades of life. Men who develop it tend to be diagnosed a few years later, around age 54 on average.
Race and ethnicity influence incidence rates, at least in some populations. A study in New York County found that Asian women had the highest rate of new diagnoses (10.5 per 100,000), followed by White women (6.2 per 100,000). Latina women (3.2) and Black women (3.3) were diagnosed at roughly half those rates. Interestingly, when researchers looked at overall prevalence rather than new cases, the differences between racial groups disappeared. This could mean the disease is equally common across groups but diagnosed more readily in some, or it could reflect genuine variation in incidence that gets diluted over time.
Among men, there were no significant differences by race or ethnicity.
Sjögren’s in Children Is Extremely Rare
Pediatric Sjögren’s disease occurs at a rate of about 0.53 per 100,000 children, making it far rarer than the adult form. The average age of onset in children is around 11, and the gender gap narrows considerably: the female-to-male ratio in kids is about 4.7 to 1, compared with 15 to 1 in adults. A large international database spanning five continents found that childhood cases made up only about 1% of all Sjögren’s diagnoses. When children do develop it, secondary Sjögren’s (occurring alongside another autoimmune disease) is relatively more common than the primary form.
Primary vs. Secondary Sjögren’s
About two-thirds of Sjögren’s cases are primary, meaning the disease develops on its own. The remaining third are secondary, appearing in people who already have another autoimmune condition. Among secondary cases, rheumatoid arthritis is the most common companion disease (about 20% of secondary cases), followed by lupus (about 8.5%). A population-based study in Madrid found the prevalence of primary Sjögren’s was 5.5 per 10,000 people, while secondary Sjögren’s came in at 2.8 per 10,000.
Why the True Number Is Likely Higher
Sjögren’s is notoriously slow to diagnose. The median time between first experiencing dry eyes or dry mouth and receiving a formal diagnosis is about two and a half years. Women wait even longer, over three years on average (155 weeks), compared to about two years and two months for men (113 weeks). Elderly women face the worst delays: those over 65 waited nearly four years on average before getting a definitive diagnosis.
Part of the problem is that dry eyes and dry mouth are incredibly common complaints with dozens of possible causes, from medications to aging to dehydration. Many people visit their doctor multiple times before anyone considers Sjögren’s. Women made a median of three outpatient visits during the diagnostic delay period, while men made two. Each of those visits represents a window where the disease could have been caught but wasn’t.
This diagnostic lag means prevalence statistics based on confirmed cases almost certainly undercount the real number of people affected. Some estimates using broader screening criteria place the prevalence significantly higher than the 61 per 100,000 figure derived from formal diagnoses.
The Lymphoma Connection
One reason the rarity of Sjögren’s matters clinically is its link to a specific type of blood cancer. People with primary Sjögren’s syndrome have roughly 30 times the risk of developing non-Hodgkin lymphoma compared to the general population. That’s one of the highest lymphoma risk ratios associated with any autoimmune disease. The absolute risk is still relatively low because non-Hodgkin lymphoma is uncommon to begin with, but it’s significant enough that doctors monitor Sjögren’s patients for warning signs like persistent swelling of the salivary glands, unexplained weight loss, or sudden changes in blood work.
This elevated risk is part of why getting an accurate diagnosis matters, even when the primary symptoms feel manageable. Knowing you have Sjögren’s changes what your doctor watches for over the years.